TBK1 and Autoimmunity: Finally, in patients with ambiguous diagnoses of human autoimmunity featuring elevated IgG4 and sicca symptoms, TNIP1-mediated disease may be present and would pave the way for pathway-targeted treatments such as TLR7 and TBK1 inhibitors.